KNSA
Companies
NASDAQ
Kiniksa Pharmaceuticals, Ltd.
Health Care
$27.93
+$8.15 (+41.20%)
Price Chart
Overview
About KNSA
kiniksa pharmaceuticals combines an experienced management team and significant committed capital in order to acquire, develop, and commercialize therapeutics treating devastating diseases with high unmet needs.
Market Cap
$1.4B
Volume
15.3M
Avg. Volume
18.2M
P/E Ratio
36.81818
Dividend Yield
0.00%
Employees
260.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.82
Moderate Correlation
Volatility
High (0.44)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, KNSA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.4B
Volume15.3M
P/E Ratio36.82
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 28, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025